Commentary on van Lancker et al.

IF 2.2 3区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Clinical Trials Pub Date : 2024-08-01 Epub Date: 2024-06-02 DOI:10.1177/17407745241251609

Frank E Harrell

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

对 van Lancker 等人的评论

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical Trials 医学-医学：研究与实验

CiteScore

4.10

自引率

3.70%

发文量

审稿时长

6-12 weeks

期刊介绍： Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy impact.

期刊最新文献

Challenges in conducting efficacy trials for new COVID-19 vaccines in developed countries. Society for Clinical Trials Data Monitoring Committee initiative website: Closing the gap. A comparison of computational algorithms for the Bayesian analysis of clinical trials. Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial. Efficient designs for three-sequence stepped wedge trials with continuous recruitment.